1. Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea
   Ana Azevedo et al, 2018, Molecular Medicine Reports CrossRef
2. Atypical haematological presentation in a case of polycythaemia vera with a new variant mutation detected in exon 12: c.1605G>T (p.Met535Ile)
   Amélia Soraia Andrade Pita et al, 2018, Journal of Clinical Pathology CrossRef
3. Non-receptor Tyrosine Kinases Role and Significance in Hematological Malignancies
   Ana Azevedo et al, 2019, Tyrosine Kinases as Druggable Targets in Cancer CrossRef
4. Preliminary study in genetic polymorphism of hOGG1 and risk factor for thyroid cancer in Indonesia
   H. N. E. Surniyantoro et al, 2021, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE AND SCHOOL ON PHYSICS IN MEDICINE AND BIOSYSTEM (ICSPMB): Physics Contribution in Medicine and Biomedical Applications CrossRef
5. Prevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population
   Ana Paula Azevedo et al, 2017, Biomedical Reports CrossRef
6. Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms
   Matteo Giaccherini et al, 2020, Blood Cancer Journal CrossRef
7. Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients
   Jhemerson F. Paes et al, 2024, Scientific Reports CrossRef